Cargando…

Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients

OBJECTIVE: To comprehensively describe the pathological features of neurons in patients with ovarian teratomas and paraneoplastic anti-NMDAR encephalitis (anti-NMDARE), emphasizing on NMDA-receptor expression and infiltrating lymphocytes. METHODS: A retrospective study was performed in a large serie...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xin-Yue, Lei, Song, Zhang, Le, Liu, Xu, Lin, Min-Tao, Blumcke, Ingmar, Piao, Yue-Shan, Zhou, Dong, Li, Jin-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414584/
https://www.ncbi.nlm.nih.gov/pubmed/32771066
http://dx.doi.org/10.1186/s40478-020-00999-2
_version_ 1783568997305810944
author Jiang, Xin-Yue
Lei, Song
Zhang, Le
Liu, Xu
Lin, Min-Tao
Blumcke, Ingmar
Piao, Yue-Shan
Zhou, Dong
Li, Jin-Mei
author_facet Jiang, Xin-Yue
Lei, Song
Zhang, Le
Liu, Xu
Lin, Min-Tao
Blumcke, Ingmar
Piao, Yue-Shan
Zhou, Dong
Li, Jin-Mei
author_sort Jiang, Xin-Yue
collection PubMed
description OBJECTIVE: To comprehensively describe the pathological features of neurons in patients with ovarian teratomas and paraneoplastic anti-NMDAR encephalitis (anti-NMDARE), emphasizing on NMDA-receptor expression and infiltrating lymphocytes. METHODS: A retrospective study was performed in a large series of 159 patients from the West China Hospital. We retrospectively identified 12 patients with paraneoplastic anti-NMDARE (11 case with ovarian teratomas and 1 case with mixed germ cell tumor), which were compared to 35 patients with teratomas and no encephalitis and to 147 patients with anti-NMDARE and no evidence for tumors. Patient history and outcome were reviewed from the clinical charts and compared between all three groups. Histopathological examination, including double-immunofluorescence of NMDAR subunits and IgG was performed in all teratoma tissues. Magnetic Luminex Assay Human Premixed Multi-Analyte Kit was performed to investigate cytokines profile of CSF. RESULTS: Patients with paraneoplastic anti-NMDARE had a more severe clinical presentation, i.e. they required more mechanical ventilation and intensive care (p < 0.001). Though immunotherapy was initiated earlier in this group, repeated intravenous immunoglobulin administration (IVIG) was more common (p = 0.002) and with higher cerebrospinal fluid (CSF) antibody titres (p = 0.004). Following tumor resection, the outcome did not differ between groups. A peculiar population of floating-frog like dysplastic neurons were observed only in teratomas of patients with paraneoplastic anti-NMDARE, co-expressing NR1, NR2A, NR2B subunits and IgG. Also, CD20 positive B-cells were more common in anti-NMDARE teratomas. In CSF of paraneoplastic anti-NMDARE patients, TNF-α, IL-10 and GM-CSF concentrations were higher than in negative symptom control and VEGF-A and IL-1a were lower than in anti-NMDARE patients (0.25 < p < 0.05). CONCLUSIONS: Patients with teratomas and paraneoplastic anti-NMDARE revealed a cellular population of dysplastic neurons co-expressing NMDAR subunits, which were the potential source of autoantigens triggering anti-NMDARE. Some inflammatory cytokines may be involved in pathogenesis of paraneoplastic anti-NMDARE.
format Online
Article
Text
id pubmed-7414584
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74145842020-08-10 Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients Jiang, Xin-Yue Lei, Song Zhang, Le Liu, Xu Lin, Min-Tao Blumcke, Ingmar Piao, Yue-Shan Zhou, Dong Li, Jin-Mei Acta Neuropathol Commun Research OBJECTIVE: To comprehensively describe the pathological features of neurons in patients with ovarian teratomas and paraneoplastic anti-NMDAR encephalitis (anti-NMDARE), emphasizing on NMDA-receptor expression and infiltrating lymphocytes. METHODS: A retrospective study was performed in a large series of 159 patients from the West China Hospital. We retrospectively identified 12 patients with paraneoplastic anti-NMDARE (11 case with ovarian teratomas and 1 case with mixed germ cell tumor), which were compared to 35 patients with teratomas and no encephalitis and to 147 patients with anti-NMDARE and no evidence for tumors. Patient history and outcome were reviewed from the clinical charts and compared between all three groups. Histopathological examination, including double-immunofluorescence of NMDAR subunits and IgG was performed in all teratoma tissues. Magnetic Luminex Assay Human Premixed Multi-Analyte Kit was performed to investigate cytokines profile of CSF. RESULTS: Patients with paraneoplastic anti-NMDARE had a more severe clinical presentation, i.e. they required more mechanical ventilation and intensive care (p < 0.001). Though immunotherapy was initiated earlier in this group, repeated intravenous immunoglobulin administration (IVIG) was more common (p = 0.002) and with higher cerebrospinal fluid (CSF) antibody titres (p = 0.004). Following tumor resection, the outcome did not differ between groups. A peculiar population of floating-frog like dysplastic neurons were observed only in teratomas of patients with paraneoplastic anti-NMDARE, co-expressing NR1, NR2A, NR2B subunits and IgG. Also, CD20 positive B-cells were more common in anti-NMDARE teratomas. In CSF of paraneoplastic anti-NMDARE patients, TNF-α, IL-10 and GM-CSF concentrations were higher than in negative symptom control and VEGF-A and IL-1a were lower than in anti-NMDARE patients (0.25 < p < 0.05). CONCLUSIONS: Patients with teratomas and paraneoplastic anti-NMDARE revealed a cellular population of dysplastic neurons co-expressing NMDAR subunits, which were the potential source of autoantigens triggering anti-NMDARE. Some inflammatory cytokines may be involved in pathogenesis of paraneoplastic anti-NMDARE. BioMed Central 2020-08-08 /pmc/articles/PMC7414584/ /pubmed/32771066 http://dx.doi.org/10.1186/s40478-020-00999-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Jiang, Xin-Yue
Lei, Song
Zhang, Le
Liu, Xu
Lin, Min-Tao
Blumcke, Ingmar
Piao, Yue-Shan
Zhou, Dong
Li, Jin-Mei
Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients
title Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients
title_full Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients
title_fullStr Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients
title_full_unstemmed Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients
title_short Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients
title_sort co-expression of nmda-receptor subunits nr1, nr2a, and nr2b in dysplastic neurons of teratomas in patients with paraneoplastic nmda-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414584/
https://www.ncbi.nlm.nih.gov/pubmed/32771066
http://dx.doi.org/10.1186/s40478-020-00999-2
work_keys_str_mv AT jiangxinyue coexpressionofnmdareceptorsubunitsnr1nr2aandnr2bindysplasticneuronsofteratomasinpatientswithparaneoplasticnmdareceptorencephalitisaretrospectiveclinicopathologystudyof159patients
AT leisong coexpressionofnmdareceptorsubunitsnr1nr2aandnr2bindysplasticneuronsofteratomasinpatientswithparaneoplasticnmdareceptorencephalitisaretrospectiveclinicopathologystudyof159patients
AT zhangle coexpressionofnmdareceptorsubunitsnr1nr2aandnr2bindysplasticneuronsofteratomasinpatientswithparaneoplasticnmdareceptorencephalitisaretrospectiveclinicopathologystudyof159patients
AT liuxu coexpressionofnmdareceptorsubunitsnr1nr2aandnr2bindysplasticneuronsofteratomasinpatientswithparaneoplasticnmdareceptorencephalitisaretrospectiveclinicopathologystudyof159patients
AT linmintao coexpressionofnmdareceptorsubunitsnr1nr2aandnr2bindysplasticneuronsofteratomasinpatientswithparaneoplasticnmdareceptorencephalitisaretrospectiveclinicopathologystudyof159patients
AT blumckeingmar coexpressionofnmdareceptorsubunitsnr1nr2aandnr2bindysplasticneuronsofteratomasinpatientswithparaneoplasticnmdareceptorencephalitisaretrospectiveclinicopathologystudyof159patients
AT piaoyueshan coexpressionofnmdareceptorsubunitsnr1nr2aandnr2bindysplasticneuronsofteratomasinpatientswithparaneoplasticnmdareceptorencephalitisaretrospectiveclinicopathologystudyof159patients
AT zhoudong coexpressionofnmdareceptorsubunitsnr1nr2aandnr2bindysplasticneuronsofteratomasinpatientswithparaneoplasticnmdareceptorencephalitisaretrospectiveclinicopathologystudyof159patients
AT lijinmei coexpressionofnmdareceptorsubunitsnr1nr2aandnr2bindysplasticneuronsofteratomasinpatientswithparaneoplasticnmdareceptorencephalitisaretrospectiveclinicopathologystudyof159patients